RSS Feed
FDA Seeks More Data on Blood Cancer Drug
The FDA has completed its review of Spectrum Pharma's drug Zevalin, but final approval of the drug will probably be delayed two months.
10:04AM 07/06/09
AMAG May Have Its Pick of Suitors
Now that the FDA has approved its iron replacement therapy, Feraheme may be ripe for takeover.
09:33AM 07/05/09
Elan Shares Rise on J&J Investment
Elan announces a $1.5 billion investment by J&J wherein it will take over Elan's Alzheimer's unit and assume an 18.4% stake in the company.
11:10AM 07/02/09
Biotech Stock Mailbag: Spectrum Pharmaceuticals
Readers weigh in on Spectrum Pharma, Cell Therapeutics and Geron, and force us to explain -- again -- TheStreet's rules on stock ownership.
09:42AM 07/02/09
Upside remains in AMAG stock price even with Feraheme approval.
11:02AM 07/01/09
Geron Fans Make Mountain Out of GE Molehill
As with most announcements from Geron, investors overreact to news of a stem-cell deal with GE.
12:41PM 06/30/09
AMAG: FDA Delays Feraheme Decision
AMAG says it expects the FDA to make its approval decision on iron replacement therapy Feraheme within a few days.
10:04AM 06/30/09
Find more premium investing ideas